SRF (SRF) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
9 Jan, 2026Executive summary
Q3 FY25 gross operating revenue reached ₹3,491.31 crore, up 14.4% year-over-year, with strong contributions from Chemicals and Packaging Films; Technical Textiles and Others faced margin pressure.
Q3 FY25 PAT was ₹271.1 crore, a 7% YoY increase, though 9M FY25 PAT declined 20.7% to ₹724.7 crore.
EBITDA for Q3 FY25 grew 15.1% YoY to ₹693.4 crore; 9M FY25 EBITDA fell 3.8% to ₹1,933.3 crore.
Unaudited consolidated and standalone financial results for Q3 and 9M FY25 were approved by the Board, with no material misstatements identified by auditors.
The company maintains a positive outlook for FY 2026, expecting to finish FY25 on a strong note.
Financial highlights
Chemicals business revenue was ₹1,495.65 crore in Q3 FY25, up 7.3% YoY; EBIT up 13% YoY.
Packaging Films revenue grew 27% YoY to ₹1,384.75 crore, with EBIT up 101.4% YoY.
Technical Textiles revenue increased 11.2% YoY to ₹509.79 crore, though EBIT declined 14.4% YoY.
Q3 FY25 EBITDA margin was 19.9%; PAT margin was 7.8%.
Export sales accounted for 40%-42% of HFC tonnage in the first nine months.
Outlook and guidance
Q4 is expected to be stronger than Q3, with specialty chemicals and refrigerant gas segments anticipated to outperform the previous year.
FY 2026 is projected to see ramp-up in new AI sales, improved PTFE utilization, and positive demand trends in key segments.
CapEx guidance for FY25 is ₹1,500 crore, with FY26 expected at ₹1,500–2,000 crore.
Board declared a second interim dividend of ₹3.60 per share, totaling ₹106.71 crore.
New HF plant commissioning to provide cost advantages in Chemicals.
Latest events from SRF
- Record Q1 revenue and profit growth, with margin expansion and interim dividend declared.SRF
Q1 26/27 - FY26 saw strong profit and margin growth led by Chemicals and Films, with major investments ahead.SRF
Q4 25/26 - Strong profit growth led by Chemicals, with interim dividend and major CapEx plans.SRF
Q3 25/26 - Q2 FY26 saw strong revenue, profit, and margin growth, driven by Chemicals and higher CapEx.SRF
Q2 25/26 - Strong revenue and profit growth, improved margins, and interim dividend declared.SRF
Q1 25/26 - Q2 FY25 revenue up 8% YoY, but profit fell 33% as margins contracted and chemicals lagged.SRF
Q2 24/25 - Profit fell 29.8% as margins contracted, but H2 recovery and interim dividend expected.SRF
Q1 2025 - FY25 revenue up 11.8% to ₹14,693 crore, net profit down 6%, no final dividend.SRF
Q4 24/25